95 related articles for article (PubMed ID: 4268457)
1. The effects of lymphocytes, sera, and long-acting thyroid stimulator from patients with Graves' disease on retrobulbar fibroblasts.
Sisson JC; Kothary P; Kirchick H
J Clin Endocrinol Metab; 1973 Jul; 37(1):17-24. PubMed ID: 4268457
[No Abstract] [Full Text] [Related]
2. Action of globulin and lymphocytes from peripheral blood of patients with Graves' disease on isolated bovine thyroid cells.
Edmonds MW; Row VV; Volpé R
J Clin Endocrinol Metab; 1970 Nov; 31(5):480-90. PubMed ID: 5536104
[No Abstract] [Full Text] [Related]
3. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
McKenzie JM; Zakarija M; D'Amour P; Joasoo A
N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
[No Abstract] [Full Text] [Related]
4. The immunoglobulin G (IgG) of Graves' disease: thyroid stimulation by fraction and fragment.
Burke G
Endocrinology; 1969 May; 84(5):1063-70. PubMed ID: 4887860
[No Abstract] [Full Text] [Related]
5. Indirect immunofluorescence and generation of cyclic-AMP investigation with Graves' patients' sera.
Szabó J; Fórizs E; Szabó T; Leövey A
Acta Med Hung; 1986; 43(3):275-81. PubMed ID: 3035480
[TBL] [Abstract][Full Text] [Related]
6. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
[TBL] [Abstract][Full Text] [Related]
7. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunological studies on the long-acting thyroid stimulator.
Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
[No Abstract] [Full Text] [Related]
9. Concentration of long-acting thyroid stimulator (LATS) by subfractionation of gamma G globulin from Graves' disease serum.
Miyai K; Werner SC
J Clin Endocrinol Metab; 1966 May; 26(5):504-12. PubMed ID: 5952570
[No Abstract] [Full Text] [Related]
10. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
Sawhney RC; Kannan V; Rastogi GK
J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
[No Abstract] [Full Text] [Related]
11. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
McKenzie JM; Zakarija M
J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
[TBL] [Abstract][Full Text] [Related]
12. Relationships among immunoglobulin markers in Graves' disease.
Ozawa Y; Maciel RM; Chopra IJ; Solomon DH; Beall GN
J Clin Endocrinol Metab; 1979 Mar; 48(3):381-7. PubMed ID: 581874
[No Abstract] [Full Text] [Related]
13. ["Long-acting thyroid stimulator" (LATS)].
Lamberg BA
Duodecim; 1969; 85(20):1253-6. PubMed ID: 5396113
[No Abstract] [Full Text] [Related]
14. Proceedings: Influence of human thyroid-stimulating hormone and immunoglobulins from patients with Graves' disease on human thyroid cyclic AMP.
Holmes SD; Dirmikis SM; Martin TJ; Munro DS
J Endocrinol; 1976 Jun; 69(3):8P-9P. PubMed ID: 181521
[No Abstract] [Full Text] [Related]
15. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
16. Inhibition of glycosaminoglycans production in retrobulbar fibroblast cultures by ethacrynic acid and hydrocortisone.
Sisson JC; Kirchick H; Kothary P
J Clin Endocrinol Metab; 1974 May; 38(5):777-82. PubMed ID: 4274696
[No Abstract] [Full Text] [Related]
17. Lymphocyte-retrobulbar fibroblast interaction: mechanisms by which stimulation occurs and inhibition of stimulation.
Sisson JC; Vanderburg JA
Invest Ophthalmol; 1972 Jan; 11(1):15-20. PubMed ID: 4331497
[No Abstract] [Full Text] [Related]
18. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
Tourneur R; Letonturier P; Sénécal P
Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
[No Abstract] [Full Text] [Related]
19. [LATS and Graves' disease].
Gordon A
Harefuah; 1971 May; 80(10):569-70. PubMed ID: 5171988
[No Abstract] [Full Text] [Related]
20. Isoelectric focusing of long-acting thyroid stimulator immunoglobulin G.
Lonergan C; Babiarz D; Burke G
J Clin Endocrinol Metab; 1973 Mar; 36(3):439-44. PubMed ID: 4631063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
